Brooklyn ImmunoTherapeutics Inc. (BTX) Social Stream
BROOKLYN IMMUNOTHERAPEUTICS INC (BTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-22 | 1 | $20 | $20 | $20 | $0.205 | 9656.1% |
| 2021-12-29 | 2 | $20 | $9 | $14.5 | $0.205 | 6973.17% |
| 2022-04-08 | 2 | $9 | $9 | $9 | $0.205 | 4290.24% |
| 2022-04-22 | 2 | $9 | $5 | $7 | $0.205 | 3314.63% |
| 2022-04-28 | 2 | $5 | $4 | $4.5 | $0.205 | 2095.12% |
| 2022-06-03 | 1 | $3 | $3 | $3 | $0.205 | 1363.41% |
| 2022-06-06 | 2 | $4 | $3 | $3.5 | $0.205 | 1607.32% |
Price Target Last Issued June 3, 2022
Over the past 32 weeks, BTX's average upside potential has been 327.38%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-22 | 1 | 20 | 20 | 20.0 | 9.010 | 121.98% |
| 2021-12-29 | 2 | 20 | 9 | 14.5 | 4.280 | 238.79% |
| 2022-04-22 | 2 | 9 | 5 | 7.0 | 1.240 | 464.52% |
| 2022-04-28 | 2 | 5 | 4 | 4.5 | 1.120 | 301.79% |
| 2022-06-06 | 2 | 4 | 3 | 3.5 | 0.612 | 471.9% |
BTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BTX as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, BROOKLYN IMMUNOTHERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 793.8% of them.
- In the context of all US stocks, BROOKLYN IMMUNOTHERAPEUTICS INC's number of analysts covering the stock is higher than 23.16% of them.
- In the context of Pharmaceutical Products stocks, BROOKLYN IMMUNOTHERAPEUTICS INC's variance in analysts' estimates is lower than -32.27% of them.
- BTX has a greater average analyst price target than 135.34% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BROOKLYN IMMUNOTHERAPEUTICS INC are BTAI, BPTH, and BOLT.
View All Top Stocks by Price Target
Make investment decisions regarding BTX using the data that counts. Try POWR Ratings for free.